Cynthia Seidel-Dugan
Chief Scientific Officer, Werewolf Therapeutics, Inc.
Companies
- Werewolf Therapeutics, Inc.Chief Scientific Officer Apr 29, 2021 to Jan 4, 20241
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Werewolf Therapeutics, Inc. HOWL164,888 shares2$170.7K at $1.03Jan 12, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 12, 2022Exercised options 15,532 shares at $4.77 of Werewolf Therapeutics, Inc.2
- Jan 12, 2022Exercised options 24,199 shares at $1.56 of Werewolf Therapeutics, Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2